Plant ribosome-inactivating proteins type II induce the unfolded protein response in human cancer cells

C Horrix1, Z Raviv, E Flescher

  • 1Toxicology and Chemotherapy Unit, German Cancer Research Center, Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. c.horrix@dkfz.de

Insights

Type II ribosome-inactivating proteins (RIPs) trigger the unfolded protein response (UPR) in cancer cells, challenging the traditional view of translational arrest as the sole mechanism of toxicity. This UPR induction better explains cellular effects at specific RIP concentrations.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Toxicology

Background:

  • Type II ribosome-inactivating proteins (RIPs), like ricin, are studied for anti-cancer potential but also as bioweapons.
  • The precise molecular mechanism of RIP toxicity, particularly the role of 28S rRNA depurination and translational arrest, is debated.

Purpose of the Study:

  • To investigate the cellular response to type II RIPs (ricin, riproximin, volkensin) in cancer cell lines.
  • To elucidate the molecular mechanism of RIP-induced cell death, focusing on the unfolded protein response (UPR).

Main Methods:

  • Microarray analysis
  • Quantitative reverse transcription PCR (qRT-PCR)
  • Western blotting
  • Exposure of HCT116 and MDA-MB-231 cells to type II RIPs.

Main Results:

  • Type II RIPs induced the unfolded protein response (UPR) in HCT116 and MDA-MB-231 cells.
  • Apoptosis occurred at RIP concentrations where UPR-related gene translation persisted despite ribosomal depurination.
  • This suggests a more complex mechanism than general translational arrest.

Conclusions:

  • UPR induction is a key cellular response to type II RIP exposure.
  • The findings challenge the paradigm that irreversible 28S rRNA depurination solely causes general translational arrest and cell death.
  • UPR induction offers a more accurate model for understanding RIP cellular effects at specific concentrations.

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...